MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (MLTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mltx · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 18 Wall Street analysts in the past 3 months
Buy
18 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$45.00
Consensus
$28.50
+59.7% upside
Low
$10.00
Median: $29.5 · Last Close: $17.84
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$28.50
59.7% upside
High Target
$45
152.2%
Low Target
$10
-44.0%
Current Price
$17.84
as of today
Based on analyst price targets, the MLTX stock price prediction for the next 12 months ranges from $10 to $45. The consensus MLTX price forecast of $28.50 implies 59.7% upside from the current price of $17.84.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $17.84 | ↓ 0.02% |
1-day model range: $17.72–$17.97. Peak: $17.97 (-0.02%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MLTX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Needham | Maintains | Buy→Buy |
| 2026-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-30 | BTIG | Maintains | Buy→Buy |
| 2026-03-23 | Wolfe Research | Upgrade ↑ | Underperform→Outperform |
| 2026-03-19 | Rothschild & Co | Upgrade ↑ | Neutral→Buy |
| 2026-03-11 | Clear Street | Maintains | Buy→Buy |
| 2026-03-02 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-26 | Needham | Maintains | Buy→Buy |
| 2026-02-24 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on MoonLake Immunotherapeutics (MLTX) stock. Of the recent 102 rating actions, 6 were upgrades and 7 were downgrades. 18 analysts currently cover MLTX.
Analyst Recommendation Trends
MLTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$23M
EPS This Year
$-3.83
EPS Next Year
$-3.64
↓ 5.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MLTX EPS of $-3.83 for the current fiscal year, based on estimates from 7 analysts. The MLTX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MLTX stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MLTX price target is $28.50 (+59.7% upside), with an analyst consensus of Buy.
The MLTX short-term stock prediction for tomorrow is $17.84 (-0.02%).
MoonLake Immunotherapeutics trades on NASDAQ under the ticker MLTX. The MLTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 78% of covering analysts.
Frequently asked questions
MLTX forecast · 8 questionsAccording to 18 Wall Street analysts, the average 12-month MLTX price target is $28.50, with a high forecast of $45.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +59.7% potential upside from the current price of $17.84.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.